Corbus Pharmaceuticals Stock (NASDAQ: CRBP) stock price, news, charts, stock research, profile.
Open | $19.08 |
Close | - |
Volume / Avg. | 1.07M / 519.38K |
Day Range | $18.04 - $19.43 |
52 Wk Range | 3.03 - 61.90 |
Market Cap | $217.51M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 12.56% |
Days to Cover | 4.75 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.
Other companies in Corbus Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Adaptimmune Therapeutics (NASDAQ:ADAP), Sangamo Therapeutics (NASDAQ:SGMO) and Kyverna Therapeutics (NASDAQ:KYTX).
Corbus Pharmaceuticals has a consensus price target of $65.86.
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $18.06 last updated September 24, 2024 at 3:47 PM EDT.
There are no upcoming dividends for Corbus Pharmaceuticals.
Corbus Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Corbus Pharmaceuticals.
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.